1
Return

Letter: FDA Approval of the HepQuant SHUNT Liver Diagnostic Test and Clarification of the SHUNT-V Analysis Cohort

delete2026-08-12
delete0
delete
OA
AI
M
Mitchell Shiffman
K
K. Rajender Reddy
M
Michael D. Leise
K
Kamran Qureshi
A
Alastair D. Smith
S
Steve Helmke
J
John Kittelson
M
Michael P. McRae
J
Joanne C. Imperial
G
Gregory T. Everson *
DOI:10.1111/apt.70925delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

A
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF:
6.7
Papers:
422
Citations:
0

Organization

U
university of colorado anschutz medical center
Scholars:
4
Papers: 3
Citations: 0
B
bon secours liver institute of virginia
Scholars:
2
Papers: 1
Citations: 0
S
st. louis university school of medicine
Scholars:
3
Papers: 2
Citations: 0
U
University of Pennsylvania
Scholars:
1.0W
Papers: 3.7K
Citations: 11.8W
M
mayo clinic
Scholars:
8.0W
Papers: 6.5W
Citations: 84
H
HepQuant LLC
Scholars:
7
Papers: 3
Citations: 0
C
custom dx solutions llc
Scholars:
4
Papers: 4
Citations: 0
S
syneos health
Scholars:
13
Papers: 11
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers